Aditxt shared its growth vision under the bitXbio™ strategy, aiming to connect public markets, blockchain, and Web3 for advancing health innovations.
The Company filed a preliminary proxy statement seeking shareholder approval for an Employee Stock Purchase Plan and a proposed name change to bitXbio, Inc.
The strategic evolution includes plans for a Digital Asset Treasury and partnerships such as Pearsanta's IPO and Evofem's focus on regaining a national listing.
bitXbio™ Strategy
Connects public markets, blockchain, and Web3 to advance health innovations and engage a global community of shareholders.
Employee Stock Purchase Plan
Designed to align employees with shareholders by allowing them to purchase company stock through payroll deductions.
Name Change Proposal
Proposed change from Aditxt, Inc. to bitXbio, Inc. to reflect the broader transition into a life sciences platform.
Digital Asset Treasury
Planned blockchain-enabled financial architecture to capture potential value across innovative health companies.
Ventures & Partnerships
Pearsanta's planned IPO and Evofem's focus on regaining a national listing represent strategic moves in Aditxt's growth plan.
- The bitXbio strategy aims to decentralize participation in health innovation, enabling transparent engagement and aligning interests among stakeholders.
- The Employee Stock Purchase Plan is intended to strengthen the ownership culture within Aditxt and support the Company's long-term growth plan.
- The proposed Digital Asset Treasury seeks to create a hybrid treasury model to represent potential value creation by Aditxt's portfolio of companies.
Aditxt's strategic initiatives highlight a shift towards a participatory life sciences platform, embracing blockchain technology. The planned IPO of Pearsanta and Evofem's focus on growth signify key milestones in Aditxt's ambitious 2026 goals.